Literature DB >> 14714742

Preventable factors in childhood that lead to insulin resistance, diabetes mellitus and the metabolic syndrome: the EarlyBird diabetes study 1.

Linda D Voss1, Joanne Kirkby, Brad S Metcalf, Alison N Jeffery, Christina O'Riordan, Michael J Murphy, Terence J Wilkin.   

Abstract

For a decade or more, poor nutrition during gestation, expressed as low weight at birth, was held to be the factor responsible for insulin resistance later in life. Birth weights, however, are rising and insulin resistant states, such as diabetes mellitus, faster still. Alternative explanations are needed to explain insulin resistance in contemporary industrialised populations. EarlyBird is a non-intervention prospective cohort study that asks the question 'Which children develop insulin resistance, and why?' It is unique in taking serial blood samples from a young age with which to monitor the behaviour of insulin resistance and its metabolic correlates. This, the baseline report of the EarlyBird Study, describes the rationale, design and methodology of the study, and the profile of the population at entry. It situates the anthropometric, physical activity and dietary status of the EarlyBird children and provides a detailed metabolic profile of the British 5 year-old in the year 2000.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14714742     DOI: 10.1515/jpem.2003.16.9.1211

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  13 in total

1.  Physical activity cost of the school run: impact on schoolchildren of being driven to school (EarlyBird 22).

Authors:  Brad Metcalf; Linda Voss; Alison Jeffery; Jenny Perkins; Terry Wilkin
Journal:  BMJ       Date:  2004-08-18

2.  Parents' awareness of overweight in themselves and their children: cross sectional study within a cohort (EarlyBird 21).

Authors:  A N Jeffery; L D Voss; B S Metcalf; S Alba; T J Wilkin
Journal:  BMJ       Date:  2004-11-26

3.  Ethical dilemmas: feeding back results to members of a longitudinal cohort study.

Authors:  A Jeffery; R Snaith; L Voss
Journal:  J Med Ethics       Date:  2005-03       Impact factor: 2.903

4.  The great weight gain experiment, accelerators, and their implications for autoantibodies in diabetes.

Authors:  T J Wilkin
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

5.  Changing perspectives in diabetes: their impact on its classification.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  2007-04-25       Impact factor: 10.122

6.  Evidence for energy conservation during pubertal growth. A 10-year longitudinal study (EarlyBird 71).

Authors:  M Mostazir; A Jeffery; J Hosking; B Metcalf; L Voss; T Wilkin
Journal:  Int J Obes (Lond)       Date:  2016-09-08       Impact factor: 5.095

7.  Childhood obesity: evidence for distinct early and late environmental determinants a 12-year longitudinal cohort study (EarlyBird 62).

Authors:  M Mostazir; A Jeffery; L Voss; T Wilkin
Journal:  Int J Obes (Lond)       Date:  2015-04-27       Impact factor: 5.095

8.  Physical activity attenuates the mid-adolescent peak in insulin resistance but by late adolescence the effect is lost: a longitudinal study with annual measures from 9-16 years (EarlyBird 66).

Authors:  Brad S Metcalf; Joanne Hosking; William E Henley; Alison N Jeffery; Mohammod Mostazir; Linda D Voss; Terence J Wilkin
Journal:  Diabetologia       Date:  2015-08-12       Impact factor: 10.122

9.  Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26).

Authors:  Alison N Jeffery; Brad S Metcalf; Joanne Hosking; Adam J Streeter; Linda D Voss; Terence J Wilkin
Journal:  Diabetes Care       Date:  2012-01-25       Impact factor: 19.112

10.  Objectively measured physical activity and its association with adiponectin and other novel metabolic markers: a longitudinal study in children (EarlyBird 38).

Authors:  Brad S Metcalf; Alison N Jeffery; Joanne Hosking; Linda D Voss; Naveed Sattar; Terence J Wilkin
Journal:  Diabetes Care       Date:  2008-11-25       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.